DocMorris targets double-digit non-prescription growth

25 March 2022 - Deborah Wilkes

Premium

Switzerland’s Zur Rose Group said it wanted the DocMorris brand to achieve “double-digit growth in non-prescription products” in 2022, as the group reported external revenue up by 14.8% in local currencies in 2021.

Click tags below for more information on topics:

Zur Rose

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: